References
- Barnhart, K., Hummel, A.C., Sammel, M.D., Menon, S., Jain, J., & Chakhtoura, N. (2007). Use of ‘‘2-dose’’ regimen of methotrexate to treat ectopic pregnancy. Fertility and Sterility, 87, 250–256. doi:http://dx.doi.org/10.1016/j.fertnstert.2006.06.054.
- Bleyer, W. (1978). The clinical pharmacology of methotrexate: New applications of an old drug. Cancer, 41, 36–51. doi: 10.1002/1097-0142(197801)41:1 < 36::AID-CNCR2820410108 >3.0.CO;2-I.
- Boots, C.E., Gustofson, R.L., & Feinberg, E.C. (2013). Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness? Fertility and Sterility, 100, 1590–1593. doi: http://dx.doi.org/10.1016/j.fertnstert.2013.08.007.
- Broer, S.L., Broekmans, F.J., Laven, J.S., & Fauser, B.C. (2014). Anti-müllerian hormone: Ovarian reserve testing and its potential clinical implications. Human Reproduction Update, 20, 688–701. doi:10.1093/humupd/dmu020.
- Cattanach, J.F. & Milne, B.J. (1988). Post-tubal sterilization problems correlated with ovarian steroidogenesis. Contraception, 38, 541–550. doi:10.1016/0010-7824(88)90157-6.
- Chan, C.C., Ng, E.H., Li, C.F., & Ho, P.C. (2003). Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy. Human Reproduction, 18, 2175–2180. doi: 10.1093/humrep/deg411.
- Crochet, J.R., Bastian, L.A., & Chireau, M.V. (2013). Does this woman have an ectopic pregnancy?: The rational clinical examination systematic review. The Journal of the American Medical Association, 309, 1722–1729. doi:10.1001/jama.2013.3914.
- de Vet, A., Laven, J.S., de Jong, F.H., Themmen, A.P., & Fauser, B.C. (2002). Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertility and Sterility, 77, 357–362. doi: http://dx.doi.org/10.1016/S0015-0282(01)02993-4.
- Ercan, C.M., Sakinci, M., Coksuer, H., Keskin, U., Tapan, S., & Ergun, A. (2013). Ovarian reserve testing before and after laparoscopic tubal bipolar electrodesiccation and transection. European Journal of Obstetrics & Gynecology and Reproductive Biology, 166, 56–60. doi:10.1016/j.ejogrb.2012.09.013.
- Fernandez, H., Capmas, P., Lucot, J.P., Resch, B., Panel, P., & Bouyer, J. (2013). Fertility after ectopic pregnancy: The DEMETER randomized trial. Human Reproduction, 28, 1247–1253. doi: 10.1093/humrep/det037.
- Feyereisen, E., Méndez-Lozano, D., Taieb, J., Hesters, L., Frydman, R., & Fanchin, R. (2006). Anti-müllerian hormone: Clinical insights into a promising biomarker of ovarian follicular status. Reproductive Biomedicine Online, 12, 695–703. doi: http://dx.doi.org/10.1016/S1472-6483(10)61081-4.
- Fylstra, D.L. (2012). Ectopic pregnancy not within the (distal) fallopian tube: Etiology, diagnosis, and treatment. American Journal of Obstetrics and Gynecology, 206, 289–299. doi:10.1016/j.ajog.2011.10.857.
- Gnoth, C., Schuring, A.N., Friol, K., Tigges, J., Mallmann, P., & Godehardt, E. (2008). Relevance of anti-müllerian hormone measurement in a routine IVF program. Human Reproduction, 23, 1359–1365. doi: 10.1093/humrep/den108.
- Gougeon, A. (1986). Dynamics of follicular growth in the human: A model from preliminary results. Human Reproduction, 1, 81–87. Retrieved from http://humrep.oxfordjournals.org/content/1/2/81.
- Hill, M.J., Cooper, J.C., Levy, G., Alford, C., Richter, K.S., DeCherney, A.H., … Wolff, E.F. (2014). Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location. Fertility and Sterility, 101, 413–419. doi:http://dx.doi.org/10.1016/j.fertnstert.2013.10.027.
- Khan, K.S., Wojdyla, D., Say, L., Gülmezoglu, A.M., & Van Look, P.F. (2006). WHO analysis of causes of maternal death: A systematic review. Lancet, 367, 1066–1074. doi:10.1016/S0140-6736(06)68397-9.
- Kwee, J., Schats, R., McDonnell, J., Themmen, A., de Jong, F., & Lambalk, C. (2008). Evaluation of anti-müllerian hormone as a test for the prediction of ovarian reserve. Fertility and Sterility, 90, 737–743. doi:http://dx.doi.org/10.1016/j.fertnstert.2007.07.1293.
- Lipscomb, G. (2007). Medical therapy for ectopic pregnancy. Seminars in Reproductive Medicine, 25, 93–98. doi: 10.1055/s-2007-970048.
- Liu, J., Van Der Elst, J., Van Den Broecke, R., Dumortier, F., & Dhont, M. (2000). Maturation of mouse primordial follicles by combination of grafting and in vitro culture. Biology of Reproduction, 62, 1218–1223. doi: 10.1095/biolreprod62.5.1218.
- McLaren, J.F., Burney, R.O., Milki, A.A., Westphal, L.M., Dahan, M.H., & Lathi, R.B. (2009). Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation. Fertility and Sterility, 92, 515–519. doi: http://dx.doi.org/10.1016/j.fertnstert.2008.07.009.
- Moragianni, V.A. (2014). Methotrexate treatment of ectopic pregnancies does not affect ovarian reserve in in vitro fertilization patients. Fertility and Sterility, 101, 337–338. doi: http://dx.doi.org/10.1016/j.fertnstert.2013.11.010.
- Morgan, S., Anderson, R.A., Gourley, C., Wallace, W.H., & Spears, N. (2012). How do chemotherapeutic agents damage the ovary? Human Reproduction Update, 18, 525–535. doi:10.1093/humupd/dms022.
- Nicosia, S.V., Matus-Ridley, M., & Meadows, A.T. (1985). Gonadal effects of cancer therapy in girls. Cancer, 55, 2364–2372. doi:10.1002/1097-0142(19850515)55:10 < 2364:AID-CNCR2820551011 > 3.0.CO;2-E.
- Nugent, N., Deirow, D., Brook, P.F., Aubard, Y., & Gosden, R.G. (1997). Transplantation in reproductive medicine: Previous experience, present knowledge and future prospects. Human Reproduction Update, 3, 267–280. doi: 10.1093/humupd/3.3.267.
- Oriol, B., Barrio, A., Pacheco, A., Serna, J., Zuzuarregui, J.L., & Garcia-Velasco, J.A. (2008). Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertility and Sterility, 90, 1579–1582. DOI: http://dx.doi.org/10.1016/j.fertnstert.2007.08.032.
- Seifer, D.B. & Maclaughlin, D.T. (2007). Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertility and Sterility, 88, 539–546. doi: http://dx.doi.org/10.1016/j.fertnstert.2007.02.014.
- Sezik, M., Ozkaya, O., Demir, F., Sezik, H.T., & Kaya, H. (2007). Total salpingectomy during abdominal hysterectomy: Effects on ovarian reserve and ovarian stromal blood flow. The Journal of Obstetrics and Gynaecology Research, 33, 863–869. doi: 10.1111/j.1447-0756.2007.00669.x.
- Silva, A.L., da Ré, C., Dietrich, C., Fuhrmeister, I.P., Pimentel, A., & Corleta, H.V. (2013). Impact of tubal ligation on ovarian reserve as measured by anti-müllerian hormone levels: A prospective cohort study. Contraception, 88, 700–705. doi:10.1016/j.contraception.2012.09.021.
- Stern, C., Toledo, M., Gook, D., & Seymour, J. (2006). Fertility preservation in female oncology patients. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 46, 15–23. doi: 10.1111/j.1479-828X.2006.00507.x.
- Streuli, I., Fraisse, T., Pillet, C., Ibecheole, V., Bischof, P., & de Ziegler, D. (2008). Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertility and Sterility, 90, 395–400. doi: http://dx.doi.org/10.1016/j.fertnstert.2007.06.023.
- Uyar, I., Yucel, O.U., Gezer, C., Gulhan, I., Karis, B., Hanhan, H.M., & Ozeren, M. (2013). Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy. Fertility and Sterility, 100, 1310–1313. doi:http://dx.doi.org/10.1016/j.fertnstert.2013.06.040.
- von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gøtzsche, P.C., & Vandenbroucke, J.P. (2014). STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. International Journal of Surgery, 12, 1495–1499. doi: http://dx.doi.org/10.1016/j.ijsu.2014.07.013.
- Warne, G.L., Fairley, K.F., Hobbs, J.B., & Martin, F.I. (1973). Cyclophosphamide-induced ovarian failure. New England Journal of Medicine, 289, 1159–1162. doi: 10.1056/NEJM197311292892202.
- Wiser, A., Gilbert, A., Nahum, R., Orvieto, R., Haas, J., Hourvitz, A., … Tulandi, T. (2013). Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle. Reproductive Biomedicine Online, 26, 449–453. doi: http://dx.doi.org/10.1016/j.rbmo.2013.01.018.
- Ye, X.P., Yang, Y.Z., & Sun, X.X. (2015). A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. American Journal of Obstetrics and Gynecology, 212, 53e1–5310. doi:http://dx.doi.org/10.1016/j.ajog.2014.07.027.